109 related articles for article (PubMed ID: 21353015)
21. Once-daily vs. twice-daily intrapleural urokinase treatment of complicated parapneumonic effusion in paediatric patients: A randomised, prospective study.
Wang JN; Yao CT; Yeh CN; Liu CC; Wu MH; Chuang HY; Wu JM
Int J Clin Pract; 2006 Oct; 60(10):1225-30. PubMed ID: 16981967
[TBL] [Abstract][Full Text] [Related]
22. Intrapleural alteplase therapy: what are the knowns and unknowns?
Staša J; Gregorová J; Pauk N
Cas Lek Cesk; 2019; 158(7-8):295-299. PubMed ID: 31995996
[TBL] [Abstract][Full Text] [Related]
23. Management of Noncommunicating Multiloculated Pleural Space Infection With Fibrinolytic Augmented Multiple Chest Tube Drainage.
Biswas A; Jantz MA; Barnes MD; Mehta HJ
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):e14-7. PubMed ID: 27058724
[No Abstract] [Full Text] [Related]
24. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
[TBL] [Abstract][Full Text] [Related]
25. A study of loculated tuberculous pleural effusions treated with intrapleural urokinase.
Cases Viedma E; Lorenzo Dus MJ; González-Molina A; Sanchis Aldás JL
Respir Med; 2006 Nov; 100(11):2037-42. PubMed ID: 16580190
[TBL] [Abstract][Full Text] [Related]
26. Hemothorax following administration of intrapleural alteplase.
Ruiz A; Porcel JM; Madroñero AB; Galindo C
Respiration; 2006; 73(5):715. PubMed ID: 17008788
[No Abstract] [Full Text] [Related]
27. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
[TBL] [Abstract][Full Text] [Related]
28. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model.
Zhu Z; Hawthorne ML; Guo Y; Drake W; Bilaceroglu S; Misra HL; Light RW
Chest; 2006 Jun; 129(6):1577-83. PubMed ID: 16778278
[TBL] [Abstract][Full Text] [Related]
29. Thrombolytic treatment in acute myocardial infarction.
Verstraete M
Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
[TBL] [Abstract][Full Text] [Related]
30. Intrapleural Alteplase and Dornase in a Pregnant Woman With Complicated Parapneumonic Effusion.
Amariei DE; Tran BC; Yao R; Britt EM; Holden VK; Sachdeva A; Pickering EM
Ann Thorac Surg; 2019 Nov; 108(5):e293-e294. PubMed ID: 30978314
[TBL] [Abstract][Full Text] [Related]
31. The Use of Intrapleural Thrombolytic or Fibrinolytic Therapy, or Both, via Indwelling Tunneled Pleural Catheters With or Without Concurrent Anticoagulation Use.
Gilbert CR; Wilshire CL; Chang SC; Gorden JA
Chest; 2021 Aug; 160(2):776-783. PubMed ID: 33745991
[TBL] [Abstract][Full Text] [Related]
32. Instillation of fibrinolytic enzymes in the treatment of pleural empyema.
Fraedrich G; Hofmann D; Effenhauser P; Jander R
Thorac Cardiovasc Surg; 1982 Feb; 30(1):36-8. PubMed ID: 6179231
[TBL] [Abstract][Full Text] [Related]
33. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens.
Gilbert CR; Gorden JA
Curr Opin Pulm Med; 2017 Jul; 23(4):371-375. PubMed ID: 28399008
[TBL] [Abstract][Full Text] [Related]
34. [Use of intrapleural urokinase in children].
Tapia Ceballos L; Picazo Angelín B; Bonillo Perales A; Romero Sánchez J; Díaz Cabrera R; Romero González J
An Esp Pediatr; 2000 Mar; 52(3):281-4. PubMed ID: 11003910
[TBL] [Abstract][Full Text] [Related]
35. Should all stroke patients receive tissue plasminogen activator therapy, despite mild or improving symptoms?
Lyden PD
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):184-5. PubMed ID: 16568123
[No Abstract] [Full Text] [Related]
36. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
[TBL] [Abstract][Full Text] [Related]
37. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial.
Tuncozgur B; Ustunsoy H; Sivrikoz MC; Dikensoy O; Topal M; Sanli M; Elbeyli L
Int J Clin Pract; 2001 Dec; 55(10):658-60. PubMed ID: 11777287
[TBL] [Abstract][Full Text] [Related]
38. The use of alteplase to restore patency of central venous lines in pediatric patients: a cohort study.
Choi M; Massicotte MP; Marzinotto V; Chan AK; Holmes JL; Andrew M
J Pediatr; 2001 Jul; 139(1):152-6. PubMed ID: 11445811
[TBL] [Abstract][Full Text] [Related]
39. Efficacy, safety and tolerability of streptokinase in multiloculated empyema.
Khan N; Mian I; Javed A; Wazir S; Yousaf M
J Ayub Med Coll Abbottabad; 2003; 15(4):20-2. PubMed ID: 15067826
[TBL] [Abstract][Full Text] [Related]
40. Tube thoracostomy in the management of pleural fluid collections.
Nwofor AM; Ekwunife CN
Niger J Clin Pract; 2006 Jun; 9(1):77-80. PubMed ID: 16986295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
